Chinese Covid vax found 50.4% effective in Brazil trials

5

Sao Paulo, Jan 14 | A leading Chinese Covid-19 vaccine, developed by Sinovac Biotech, has been found to be 50.4 per cent effective in Brazilian clinical trials, researchers have found.

According to the latest results released by researchers, it shows the vaccine is significantly less effective than previous data suggested — barely over the 50 per cent needed for regulatory approval.

Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body’s immune system to the virus without risking a serious disease response.

Several countries, including Indonesia, Turkey and Singapore, have placed orders for the vaccine, BBC reported on Thursday.

Last week, researchers at the Butantan Institute, which has been conducting the trials in Brazil, announced that the vaccine had a 78 per cent efficacy against “mild-to-severe” Covid-19 cases.

But, on Tuesday, they revealed that calculations for this figure did not include data from a group of “very mild infections” among those who received the vaccine that did not require clinical assistance.

With the inclusion of this data, the efficacy rate is now 50.4 per cent, said researchers.

But, the researchers stressed that the vaccine is 78 per cent effective in preventing mild cases that needed treatment and 100 per cent effective in staving off moderate to serious cases.

The Sinovac trials have yielded different results across different countries.

Last month, Turkish researchers said the Sinovac vaccine was 91.25 per cent effective, while Indonesia, which rolled out its mass vaccination programme on Wednesday, said it was 65.3 per cent effective. Both were interim results from late-stage trials.

A figure for efficacy is reached by looking at how many people developed Covid after being given the vaccine, compared with how many were affected when given a dummy injection. Normally, that is based on people developing obvious symptoms but in this Brazilian trial, people with no symptoms also appear to have been included.

Brazil has been one of the countries worst affected by Covid-19.

Source: IANS

Sponsors Posts

1BHK Flats in Jabalpur for sale at budget price ?

1BHK Flats in Jabalpur for sale at budget price ?

Approximate 200+ 1BHK apartments or flats in Jabalpur available for sale at budget price

As per available data with BhaskarProperty.com approximate 200+ 1BHK Residential Flats for Sale in Jabalpur at a very low price. This is the right time for small property buyer to grab new property in Jabalpur with multiple benefits.

At this time Builder and Developer in Jabalpur also target to the maximum sale before the end of year. Also banks are giving low rate loan for housing. The 1BHK Flats for sale at multiple prime residential location in Jabalpur are available.

1BHK apartment’s starting price in Jabalpur is 12.0 Lac*

Some of the Real Estate Developer in Jabalpur are offering 1BHK Flat at Just 12.0 Lac (Starting Price) with multiple benefits like lift, parking, 24×7 water, CCTV and many more.

You can find more details about these from bhaskarproperty.com a Jabalpur Real Estate Website.

Most preferred residential location in Jabalpur

The most preferred residential locations in Jabalpur are Civil Lines, Vijay Nagar, Kachnar City, Napier Town, Wright Town, Lekha Nagar, Sadar, Sneh Nagar, Hathital and many more.

BhaskarProperty.com is the best property portal for Jabalpur Real Estate market

The Bhaskar Property (bhaskarproperty.com) have property’s photos, video, walkthrough, location map and property browser with information. Also they provide the direct contact details of property owner and agent to whom a property buyer can directly contact.

Don’t forget to visit bhaskarproperty.com now.

LEAVE A REPLY

Please enter your comment!
Please enter your name here